One of the major challenges in gene therapy for AIDS as well as other diseases is to achieve more efficient transduction of CD34+ hematopoietic progenitor cells and maintenance of efficient expression following differentiation into mature progeny cells. Most current protocols utilizing murine retroviral vectors have proven to be relatively inefficient for transduction of human stem cells and for maintenance of long term and efficient expression of differentiated human T-cells. We propose to model novel approaches to stem cell gene transfer utilizing primate and human retroviral sequences. We will use the human immunodeficiency virus (HIV) and related simian immunodeficiency virus (SIV) genomes to develop vectors that will be more efficient for transduction of human stem cells and expression in mature T-cells. Potential advantages of utilizing human retrovirus vectors are: 1) efficient and sustained expression in the cells that are the target of HIV- 1, mature CD4+ T cells; 2) the ability to establish infection of cells at different points in the cell cycle; and 3) the potentially inducible nature of such vectors. Of particular importance we have developed an in vivo model for stem cell gene therapy utilizing the severe combined immunodeficient (SCID) mouse reconstituted with a human self-renewing thymus (SCID-hu). We have shown that this model allows transduction of CD34+ cells, leading to differentiation into mature T-cells containing the vector. The SCID-hu mice can be infected with HIV-1, resulting in T-cell depletion. Thus, it will be possible for us to test these vectors both in the laboratory and in a self-reconstituting hematopoietic environment in vivo to assess efficacy as well as potential toxic effects upon lymphoid cell differentiation.
The Specific Aims are to; 1 Develop constitutively expressing and inducible vectors for stem cell gene transfer based upon the HIV and SIV genomes; 2) In vivo modeling of vector strategies; evaluation of persistence, expression and effects on lymphoid differentiation in the SCID-hu model; and 3) Following introduction of model anti-HIV gene therapeutic reagents such as ribozymes into the above vectors, we will retest vector efficiency and determine efficacy against HIV-1 infection in T-cells in vitro and in SCID-hu mice.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI039975-01A1
Application #
2004812
Study Section
AIDS and Related Research Study Section 3 (ARRC)
Project Start
1997-04-01
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Pang, Shen; Pokomo, Lauren; Chen, Kevin et al. (2014) High-throughput screening of effective siRNAs using luciferase-linked chimeric mRNA. PLoS One 9:e96445
Shimizu, Saki; Kamata, Masakazu; Kittipongdaja, Panyamol et al. (2009) Characterization of a potent non-cytotoxic shRNA directed to the HIV-1 co-receptor CCR5. Genet Vaccines Ther 7:8
Kamata, Masakazu; Susanto, Melisa T; Chen, Irvin S Y (2009) Enhanced transthyretin tetramer stability following expression of an amyloid disease transsuppressor variant in mammalian cells. J Gene Med 11:103-11
Morizono, Kouki; Xie, Yiming; Helguera, Gustavo et al. (2009) A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. J Gene Med 11:655-63
Morizono, Kouki; Pariente, Nonia; Xie, Yiming et al. (2009) Redirecting lentiviral vectors by insertion of integrin-tageting peptides into envelope proteins. J Gene Med 11:549-58
Liang, Min; Pariente, Nonia; Morizono, Kouki et al. (2009) Targeted transduction of CD34+ hematopoietic progenitor cells in nonpurified human mobilized peripheral blood mononuclear cells. J Gene Med 11:185-96
Pariente, Nonia; Mao, Si-Hua; Morizono, Kouki et al. (2008) Efficient targeted transduction of primary human endothelial cells with dual-targeted lentiviral vectors. J Gene Med 10:242-8
An, Dong Sung; Donahue, Robert E; Kamata, Masakazu et al. (2007) Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc Natl Acad Sci U S A 104:13110-5
Pariente, Nonia; Morizono, Kouki; Virk, Mandeep S et al. (2007) A novel dual-targeted lentiviral vector leads to specific transduction of prostate cancer bone metastases in vivo after systemic administration. Mol Ther 15:1973-81
An, Dong Sung; Poon, Betty; Ho Tsong Fang, Raphael et al. (2007) Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 14:391-6

Showing the most recent 10 out of 23 publications